GO:0034128 negative regulation of MyD88-independent toll-like receptor signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034128 describes any process that stops, prevents, or reduces the frequency, rate, or extent of the MyD88-independent toll-like receptor signaling pathway [1, 2].
• The MyD88-independent pathway is also known as the TRIF-dependent or TICAM-1-dependent pathway and is primarily activated by TLR3 and TLR4 [4, 8].
• Negative regulators such as SIGIRR, SOCS1, and microRNA-7 can suppress this pathway at multiple levels, including receptor expression and adaptor function [1, 2].
• Dysregulation of this pathway is linked to impaired bacterial clearance, chronic inflammation, and altered immune responses in diseases such as melioidosis and sepsis [2, 3].
• CRISPR-based knockout, knock-in, and overexpression models are essential to dissect the causal roles of negative regulators in this pathway [1, 2, 7].
• Understanding this process provides therapeutic opportunities for modulating host immunity in infectious and inflammatory diseases.
Description
The MyD88-independent toll-like receptor (TLR) signaling pathway is a critical branch of innate immunity that operates independently of the canonical adaptor MyD88, relying instead on TRIF (TICAM-1) to mediate responses to specific TLR ligands such as double-stranded RNA and lipopolysaccharide (LPS) [4, 8]. This pathway is essential for the production of type I interferons and inflammatory cytokines, and its dysregulation can lead to severe immunopathology [3, 6]. The Gene Ontology term GO:0034128, negative regulation of MyD88-independent toll-like receptor signaling pathway, captures the diverse mechanisms that cells employ to restrain this pathway, preventing excessive or prolonged inflammation [1, 2]. Researchers study this process to understand how pathogens evade immunity and how chronic inflammatory diseases arise [2, 4]. The negative regulation of MyD88-independent TLR signaling is mediated by a variety of molecules, including signal regulatory protein alpha (SIRP-alpha), microRNA-7, and suppressors of cytokine signaling (SOCS) [1, 2]. These regulators act at different nodes of the pathway, from receptor availability to adaptor degradation, ensuring a balanced immune response [1, 2]. This article synthesizes current knowledge on the mechanisms, key genes, and experimental models used to investigate GO:0034128, providing a resource for researchers aiming to manipulate this pathway for therapeutic benefit [4, 7].
negative regulation of MyD88-independent toll-like receptor signaling pathway At A Glance
| GO ID | GO:0034128 |
|---|---|
| GO term | negative regulation of MyD88-independent toll-like receptor signaling pathway |
| Ontology | biological_process |
| Synonym | negative regulation of MyD88-independent TLR signaling pathway; negative regulation of MyD88-independent toll-like receptor signalling pathway |
| Major function | Suppression of TRIF-dependent TLR signaling to prevent excessive inflammation and maintain immune homeostasis |
| Related pathway | Toll-like receptor signaling, TRIF-dependent pathway |
| Key regulators | SIRP-alpha, microRNA-7, SOCS1, SIGIRR, etc. |
| Associated diseases | Melioidosis, sepsis, chronic inflammatory diseases |
What Is GO:0034128?
GO:0034128 is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of the MyD88-independent toll-like receptor signaling pathway [1, 2]. In other words, it encompasses all molecular events that negatively regulate the TRIF-dependent branch of TLR signaling, which is activated by TLR3 and TLR4 and leads to the activation of IRF3 and NF-kappa-B [4, 8]. This regulation can occur through the induction of inhibitory proteins, microRNAs, or post-translational modifications that interfere with signaling components [1, 2].
Why Is negative regulation of MyD88-independent toll-like receptor signaling pathway Important in Cell Biology?
The negative regulation of MyD88-independent TLR signaling is crucial for preventing uncontrolled inflammation and autoimmunity, as excessive activation of this pathway can lead to tissue damage and septic shock [3, 4]. Moreover, pathogens such as Burkholderia pseudomallei exploit this regulation to evade host immunity, highlighting its importance in infectious diseases. Understanding these regulatory mechanisms can inform the development of novel therapeutics for inflammatory disorders and infections.
• Prevents excessive inflammatory responses that can cause tissue damage and sepsis [3, 4].
• Modulates host defense against bacterial pathogens like Burkholderia pseudomallei.
• Influences the maturation and function of dendritic cells and macrophages [6, 7].
• Plays a role in resistance training-induced inflammatory adaptations in elderly subjects.
• Dysregulation is associated with chronic inflammatory and autoimmune diseases.
• Provides targets for therapeutic modulation of innate immunity.
• Essential for understanding pathogen immune evasion strategies.
• Key to developing CRISPR-based models for gene function studies [1, 2, 7].
What Happens During negative regulation of MyD88-independent toll-like receptor signaling pathway?
Initiation of MyD88-independent signaling
In simple terms: First, the TLR detects a danger signal and starts a chain of events that does not need the MyD88 protein.
The MyD88-independent pathway is initiated when TLR3 or TLR4 binds to their respective ligands, such as double-stranded RNA or LPS, leading to the recruitment of the adaptor protein TRIF (TICAM-1) [4, 8]. This recruitment triggers the activation of TBK1 and IKK-epsilon, which phosphorylate IRF3, and also activates NF-kappa-B through RIP1 and TRAF6. In dendritic cells from MyD88-deficient mice, LPS still induces maturation, confirming the existence of this pathway. The pathway is evolutionarily conserved, as evidenced by the presence of a TICAM homolog in amphioxus.
Negative regulation by SIRP-alpha
In simple terms: A protein called SIRP-alpha can put the brakes on this pathway, especially during certain bacterial infections.
Signal regulatory protein alpha (SIRP-alpha) is a negative regulator of TLR signaling that impairs the MyD88-independent pathway. In Burkholderia pseudomallei-infected mouse macrophages, SIRP-alpha was shown to inhibit the MyD88-independent pathway, leading to reduced intracellular killing of the bacteria. This suggests that SIRP-alpha acts as a checkpoint to limit excessive inflammation but may also compromise bacterial clearance.
MicroRNA-7 and FAM177A
In simple terms: Small RNA molecules like microRNA-7 can also dampen the pathway by targeting specific proteins.
MicroRNA-7 negatively regulates TLR4 signaling through FAM177A, a protein that interacts with the TLR4 complex. Overexpression of microRNA-7 reduces the activation of NF-kappa-B and IRF3, thereby suppressing the MyD88-independent branch. This highlights the role of post-transcriptional regulation in fine-tuning TLR responses.
Other negative regulators and mechanisms
In simple terms: There are many other ways the cell can turn down this pathway, such as using SOCS proteins or decoy receptors.
Suppressors of cytokine signaling (SOCS) proteins, particularly SOCS1, can inhibit TRIF-dependent signaling by targeting components for degradation. Additionally, SIGIRR (single Ig IL-1-related receptor) acts as a decoy receptor that sequesters TLRs and prevents downstream signaling. These diverse mechanisms ensure that the MyD88-independent pathway is tightly controlled to avoid immunopathology.
Key Genes Involved in GO:0034128 negative regulation of MyD88-independent toll-like receptor signaling pathway
The following genes and proteins are key players in the negative regulation of MyD88-independent TLR signaling, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SIRP-alpha | Negative regulator of TLR signaling; impairs MyD88-independent pathway | Studied in Burkholderia pseudomallei infection and macrophage function |
| FAM177A | Mediates microRNA-7-mediated negative regulation of TLR4 signaling | Target for microRNA-7; potential therapeutic target in inflammation |
| SOCS1 | Inhibits TRIF-dependent signaling by targeting adaptors for degradation | Broad suppressor of cytokine signaling; studied in inflammation and autoimmunity |
| SIGIRR | Decoy receptor that sequesters TLRs and inhibits signaling | Negative regulator of TLR signaling; potential target for inflammatory diseases |
| TRIF (TICAM-1) | Adaptor protein in MyD88-independent pathway; subject to negative regulation | Central to pathway; knockout models available [4, 8] |
| TLR3 | Receptor for double-stranded RNA; activates MyD88-independent pathway | Target for negative regulation; studied in viral infections |
| TLR4 | Receptor for LPS; activates both MyD88-dependent and independent pathways | Key receptor in sepsis and inflammation [3, 5] |
| IRF3 | Transcription factor activated by TRIF; induces type I interferons | Effector of MyD88-independent pathway; regulated by negative feedback |
| NF-kappa-B | Transcription factor activated by TRIF; induces inflammatory cytokines | Central to inflammation; negatively regulated by multiple mechanisms |
| TBK1 | Kinase that phosphorylates IRF3; part of TRIF signaling | Target for negative regulation; studied in innate immunity |
| IKK-epsilon | Kinase that phosphorylates IRF3; part of TRIF signaling | Similar to TBK1; potential regulatory node |
| RIP1 | Kinase involved in TRIF-mediated NF-kappa-B activation | Subject to ubiquitination and degradation |
| TRAF6 | E3 ubiquitin ligase in TRIF signaling | Target for negative regulation by SOCS proteins |
| MyD88 | Adaptor in the other TLR pathway; not involved in this term | Used as a control in studies of MyD88-independent pathway |
| microRNA-7 | Negatively regulates TLR4 signaling via FAM177A | Potential therapeutic agent for inflammatory diseases |
| SHP-1 | Phosphatase that can negatively regulate TLR signaling | Studied in macrophage activation |
| CD47 | Ligand for SIRP-alpha; may modulate SIRP-alpha function | Potential co-regulator in TLR signaling |
| Burkholderia pseudomallei | Pathogen that exploits SIRP-alpha to evade killing | Model organism for studying MyD88-independent pathway |
How Is negative regulation of MyD88-independent toll-like receptor signaling pathway Regulated?
The negative regulation of MyD88-independent TLR signaling is itself subject to regulation by various factors. For example, the expression of SIRP-alpha can be modulated by inflammatory stimuli, and its interaction with CD47 can influence its inhibitory function. MicroRNA-7 levels are dynamically regulated during immune responses, providing a layer of post-transcriptional control. Additionally, SOCS proteins are induced by cytokines and can feedback to inhibit TLR signaling. This complex regulatory network ensures that the pathway is appropriately dampened after activation.
negative regulation of MyD88-independent toll-like receptor signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SIRP-alpha | Melioidosis, impaired bacterial clearance | Knockout mouse macrophages infected with Burkholderia pseudomallei |
| FAM177A | Inflammation, TLR4 signaling | Overexpression and knockout cell lines treated with LPS |
| SOCS1 | Autoimmunity, inflammatory diseases | Conditional knockout mice |
| SIGIRR | Colitis, autoimmunity | SIGIRR-deficient mice |
| microRNA-7 | Sepsis, inflammation | Mimic and inhibitor transfection in macrophages |
Infectious diseases
Negative regulation of the MyD88-independent pathway can impair host defense against intracellular bacteria such as Burkholderia pseudomallei, the causative agent of melioidosis. SIRP-alpha-mediated inhibition of this pathway reduces intracellular killing of the bacteria, potentially exacerbating infection. Similarly, other pathogens may exploit these regulatory mechanisms to evade immunity.
Inflammatory and autoimmune diseases
Dysregulated negative regulation of MyD88-independent signaling can lead to chronic inflammation and autoimmunity. For instance, loss of SOCS1 or SIGIRR function results in hyperactivation of TLR signaling and increased susceptibility to inflammatory diseases. Therefore, enhancing these negative regulatory mechanisms could be therapeutic in such conditions.
Sepsis and septic shock
Excessive activation of TLR4 signaling, including the MyD88-independent branch, contributes to the cytokine storm observed in sepsis. Negative regulators like microRNA-7 and SIRP-alpha may protect against septic shock by limiting inflammation, but their dysregulation can lead to uncontrolled responses [1, 2].
From negative regulation of MyD88-independent toll-like receptor signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate MyD88-independent TLR signaling? | CRISPR knockout of gene X in macrophages, followed by LPS or poly(I:C) stimulation [1, 2] |
| What is the role of a specific point mutation in a regulator? | CRISPR point mutation knock-in in cell lines |
| How does overexpression of a regulator affect pathway activity? | CRISPR-mediated overexpression or lentiviral overexpression |
| Which proteins interact with a negative regulator? | Tagged knock-in for immunoprecipitation |
| What is the impact of a regulator on bacterial killing? | Knockout macrophages infected with Burkholderia pseudomallei |
| Can we screen for novel negative regulators? | CRISPR library screening with pathway-specific reporters |
How to Study the negative regulation of MyD88-independent toll-like receptor signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify pathways and regulators affected by LPS |
| Proteomics | Protein abundance and modifications | Detect ubiquitination of signaling components |
| Reporter assay | NF-kappa-B and IRF3 activity | Screen for negative regulators |
| ELISA | Cytokine production | Measure IFN-beta and IL-6 after stimulation |
| Bacterial killing assay | Intracellular bacterial survival | Assess functional impact of SIRP-alpha |
| Confocal microscopy | Protein localization | Visualize TLR4 internalization |
| Flow cytometry | Surface marker expression | Analyze dendritic cell maturation |
Transcriptomic analysis
RNA sequencing (RNA-seq) of macrophages stimulated with LPS or poly(I:C) can reveal global changes in gene expression dependent on the MyD88-independent pathway. This approach has been used in Chinese giant salamanders to show dependency on this pathway. Comparative transcriptomics between wild-type and knockout cells can identify negative regulators.
Proteomic and interactomic approaches
Mass spectrometry-based proteomics can identify post-translational modifications and protein-protein interactions in the pathway. For example, ubiquitination of TRIF or RIP1 can be detected to understand negative regulation. Immunoprecipitation of tagged regulators followed by mass spectrometry can uncover novel binding partners.
Functional assays
Reporter assays for NF-kappa-B and IRF3 activation are standard to measure pathway activity. Cytokine production (e.g., IFN-beta, IL-6) can be quantified by ELISA. Bacterial killing assays in macrophages assess the functional consequence of negative regulation.
Imaging and flow cytometry
Confocal microscopy can visualize the localization of TLRs and adaptors. Flow cytometry can measure surface expression of TLRs and activation markers in immune cells. These methods help confirm the impact of negative regulators on receptor trafficking and cell activation.
How CRISPR Can Be Used to Study GO:0034128 negative regulation of MyD88-independent toll-like receptor signaling pathway
Knockout
CRISPR knockout of candidate negative regulators (e.g., SIRP-alpha, SOCS1) in macrophages or dendritic cells can confirm their role in suppressing the MyD88-independent pathway [1, 2]. Knockout cells typically show enhanced NF-kappa-B and IRF3 activation upon LPS or poly(I:C) stimulation.
Point Mutation
Point mutations can be introduced to disrupt specific functional domains of negative regulators, such as the ITIM domain of SIRP-alpha, to dissect their mechanism of action. This allows precise structure-function analysis without completely abolishing protein expression.
Knock-in
Knock-in of tagged versions (e.g., FLAG, HA) of negative regulators enables immunoprecipitation and proteomic studies to identify interacting partners. Knock-in of reporter genes (e.g., luciferase) under the control of pathway-responsive promoters can facilitate screening.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of negative regulators like microRNA-7 or FAM177A can suppress pathway activity and reduce inflammation. Overexpression models are useful to test therapeutic potential.
How EDITGENE Supports negative regulation of MyD88-independent toll-like receptor signaling pathway Research
Researchers studying negative regulation of MyD88-independent toll-like receptor signaling pathway-related genes often need to determine whether a candidate gene is causally involved in suppressing this pathway or is merely a bystander. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation of negative regulators in relevant immune cells.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of MyD88-independent toll-like receptor signaling pathway research.
Frequently Asked Questions About negative regulation of MyD88-independent toll-like receptor signaling pathway
What is GO:0034128?
GO:0034128 is a Gene Ontology term for any process that negatively regulates the MyD88-independent toll-like receptor signaling pathway, which is also known as the TRIF-dependent pathway [1, 2].
What genes are involved in negative regulation of MyD88-independent TLR signaling?
Key genes include SIRP-alpha, FAM177A, SOCS1, SIGIRR, and microRNA-7, among others [1, 2, 4].
How does the MyD88-independent pathway differ from the MyD88-dependent pathway?
The MyD88-independent pathway uses the adaptor TRIF instead of MyD88 and is primarily activated by TLR3 and TLR4 to induce type I interferons [4, 8].
What diseases are associated with dysregulation of this pathway?
Dysregulation is linked to infectious diseases like melioidosis, as well as sepsis and chronic inflammatory conditions [2, 3, 4].
What experimental models are used to study this pathway?
Common models include CRISPR knockout mice or cell lines, RNA-seq, reporter assays, and bacterial infection models [1, 2, 7].
How can I study negative regulators of this pathway using CRISPR?
You can use CRISPR knockout, knock-in, or overexpression to manipulate candidate genes and measure effects on NF-kappa-B and IRF3 activation [1, 2].
What is the role of SIRP-alpha in this pathway?
SIRP-alpha is a negative regulator that impairs the MyD88-independent pathway and reduces intracellular killing of Burkholderia pseudomallei.
How does microRNA-7 regulate TLR4 signaling?
MicroRNA-7 negatively regulates TLR4 signaling through FAM177A, reducing NF-kappa-B and IRF3 activation.
What methods measure MyD88-independent pathway activity?
Reporter assays, ELISA for IFN-beta, and flow cytometry for dendritic cell maturation are commonly used [1, 6].
Why is negative regulation of this pathway important for immunity?
It prevents excessive inflammation and tissue damage while allowing effective pathogen clearance [3, 4].
Conclusion
The negative regulation of the MyD88-independent toll-like receptor signaling pathway (GO:0034128) is a critical control mechanism in innate immunity, preventing immunopathology while allowing effective host defense. Key regulators such as SIRP-alpha, microRNA-7, and SOCS1 modulate this pathway at multiple levels, and their dysregulation contributes to infectious and inflammatory diseases. CRISPR-based models are indispensable for dissecting these mechanisms and developing targeted therapies. EDITGENE offers a comprehensive suite of services to support such research, from knockout to library screening.
References
- 1. Chen H et al.. 2021. MicroRNA-7 negatively regulates Toll-like receptor 4 signaling pathway through FAM177A.. Immunology 162(1):44-57 PMID: 32852789
- 2. Baral P et al.. 2012. Involvement of signal regulatory protein α, a negative regulator of Toll-like receptor signaling, in impairing the MyD88-independent pathway and intracellular killing of Burkholderia pseudomallei-infected mouse macrophages.. Infect Immun 80(12):4223-31 PMID: 22988019
- 3. Dauphinee SM et al.. 2006. Lipopolysaccharide signaling in endothelial cells.. Lab Invest 86(1):9-22 PMID: 16357866
- 4. Saikh KU. 2021. MyD88 and beyond: a perspective on MyD88-targeted therapeutic approach for modulation of host immunity.. Immunol Res 69(2):117-128 PMID: 33834387
- 5. Rodriguez-Miguelez P et al.. 2014. Role of Toll-like receptor 2 and 4 signaling pathways on the inflammatory response to resistance training in elderly subjects.. Age (Dordr) 36(6):9734 PMID: 25427999
- 6. Kaisho T et al.. 2001. Endotoxin-induced maturation of MyD88-deficient dendritic cells.. J Immunol 166(9):5688-94 PMID: 11313410
- 7. Deng J et al.. 2024. Transcriptomic analysis of spleen-derived macrophages in response to lipopolysaccharide shows dependency on the MyD88-independent pathway in Chinese giant salamanders (Andrias davidianus).. BMC Genomics 25(1):1005 PMID: 39465384
- 8. Yang M et al.. 2011. Characterization of bbtTICAM from amphioxus suggests the emergence of a MyD88-independent pathway in basal chordates.. Cell Res 21(10):1410-23 PMID: 21931360
